Investments

Onkos Surgical® is a specialty MedTech company focused on providing innovative, personalized, and comprehensive product and service offerings to orthopedic oncologists, trauma and revision surgeons to measurably improve the lives of their patients. Onkos’ design engineers work collaboratively with the Company’s surgeon customers developing custom implant solutions that leverage a combination of specialized software, imaging and 3D printing technology to provide custom manufactured tools and implants that preserve bone and joints, leading to superior, cost effective outcomes and a higher quality of life for the patient. JSD co-invested in Onkos with 1315 Capital and Canaan.

Pathnostics® is a leading precision diagnostics company focused on the rapid and accurate diagnosis and treatment of infectious disease through its proprietary and patented molecular Guidance technology. The Company’s flagship Guidance UTI test, prescribed by urologists, primary care physicians and geriatric specialists, is a rapid molecular test for pathogen identification and antibiotic sensitivity determination, that improves patient outcomes and reduces emergency room visits and hospitalizations. The Company plans to launch additional tests under the Guidance brand for new indications including “Guidance” for respiratory, GI (diarrhea), wound care and orthopedic related pathologies. Pathnostics’ foundational products also include anatomic pathology tests for cancer and women's health. JSD co-invested in Pathnostics with Water Street Healthcare Partners.